SHANGHAI, Sept. 8, 2021 /PRNewswire/ -- Frontage Shanghai announced the acquisition of 70% equity interest in Wuhan Heyan Biomedical Technology Co., Ltd. ("Heyan Biotech") Heyan Biotech, located in ...
No articles found. Beijing Heyan Technology Co., Ltd. did not contribute to any primary research papers from Nature Index journals in the current 12 month window.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results